AGL
agilon health Inc
NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES
$27.89
-0.04% today
Updated 2026-04-29
Market cap
$464.64M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-24.50
Dividend yield
—
52W range
$7 – $120
Volume
3.3M
agilon health Inc (AGL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $794.41M | $1.22B | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Revenue growth (YoY) | — | +53.4% | +24.9% | +57.0% | +80.7% | +40.4% | -2.1% |
| Cost of revenue | $765.90M | $1.12B | $1.46B | $2.28B | $4.25B | $6.06B | $6.12B |
| Gross profit | $28.51M | $94.15M | $65.74M | $111.36M | $69.67M | $4.84M | $-188.61M |
| Gross margin | 3.6% | 7.7% | 4.3% | 4.7% | 1.6% | 0.1% | -3.2% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $122.83M | $137.29M | $427.50M | $207.79M | $285.76M | $268.91M | $238.54M |
| Operating income | $-106.57M | $-56.67M | $-372.24M | $-105.38M | $-232.13M | $-292.13M | $-421.08M |
| Operating margin | -13.4% | -4.7% | -24.5% | -4.4% | -5.4% | -4.8% | -7.1% |
| EBITDA | $-64.21M | $-40.11M | $-362.16M | $-72.41M | $-167.64M | $-218.19M | $-368.86M |
| EBITDA margin | -8.1% | -3.3% | -23.8% | -3.0% | -3.9% | -3.6% | -6.2% |
| EBIT | $-105.62M | $-54.21M | $-376.83M | $-86.19M | $-187.80M | $-242.65M | $-397.45M |
| Interest expense | $9.07M | $8.13M | $6.15M | $4.48M | $6.66M | $6.18M | $6.64M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-282.59M | $-60.05M | $-406.49M | $-106.55M | $-262.60M | $-260.15M | $-405.35M |
| Net income growth (YoY) | — | +78.7% | -576.9% | +73.8% | -146.4% | +0.9% | -55.8% |
| Profit margin | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.8% |